Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6M Buy
1,305
+223
+21% +$355K 1.47% 21
2026
Q1
$1.43M Buy
1,082
+85
+9% +$116K 0.96% 33
2025
Q4
$1.07M Buy
997
+30
+3% +$31.3K 0.71% 41
2025
Q3
$936K Buy
967
+262
+37% +$206K 0.63% 44
2025
Q2
$565K Buy
705
+131
+23% +$94K 0.42% 59
2025
Q1
$380K Buy
574
+97
+20% +$70.6K 0.3% 75
2024
Q4
$331K Buy
477
+19
+4% +$13.6K 0.25% 88
2024
Q3
$382K Buy
458
+86
+23% +$76.9K 0.27% 81
2024
Q2
$380K Buy
372
+30
+9% +$28.8K 0.3% 76
2024
Q1
$332K Buy
342
+7
+2% +$6.21K 0.27% 86
2023
Q4
$254K Buy
+335
New +$221K 0.22% 93
2021
Q2
Sell
-35
Closed -$21K 133
2021
Q1
$21K Hold
35
0.02% 303
2020
Q4
$17K Buy
+35
New +$14.7K 0.02% 295

Other funds holding ASML

Valley Brook Capital Group's ASML Position: Q2 2026 in Review

Valley Brook Capital Group increased its ASML (ASML) stake by 21% in Q2 2026, buying an estimated $355K and bringing the position to 1,305 shares worth $2.6M. The position accounts for 1.47% of the portfolio, ranked #21.

Valley Brook Capital Group first reported a position in ASML in Q4 2020 and has held it in 13 quarters since. 1,445 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Valley Brook Capital Group held 1,305 shares of ASML worth $2.6M as of Q2 2026.
  • Valley Brook Capital Group bought 223 ASML shares in Q2 2026, an estimated $355K.
  • ASML made up 1.47% of Valley Brook Capital Group's portfolio in Q2 2026, its #21 holding.
  • Valley Brook Capital Group first reported a position in ASML in Q4 2020 and has held it in 13 quarters since.
  • 1,445 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.